Bioactive small molecules

Our catalog of more than 4,000 bioactive small molecules unlocks new possibilities for exploring biology and enabling early drug discovery. Designed to help researchers investigate protein targets, signaling pathways and disease mechanisms, our diverse portfolio makes it easier to find the right compounds for your next experiment. Our portfolio includes small molecule inhibitors, such as selective kinase and cell signaling inhibitors, agonists, and toxins. These compounds are useful tools for biochemical, biophysical, and cell-based assays.
Furthermore, our partnership with the Structural Genomics Consortium provides highly characterized, novel chemical probes that guide early small molecule drug discovery from hit identification to target validation. Explore our collection of these highly adaptable research tools to discover the compounds that can accelerate your drug discovery.
Need help finding a bioactive small molecule?
Use our bioactive small molecule explorer to find your fit-for-purpose probe.

Bioactive small molecule inhibitors
Discover our portfolio of bioactive small molecule inhibitors for dissecting biological systems, validating drug targets, and advancing cancer therapy.
Bioactive small molecule agonists
Discover our collection of bioactive small molecule agonists for signaling pathways, drug discovery, and cancer and cardiovascular disease research.

Explore more categories
Explore our collection of bioactive small molecule toxins for toxicology, signal transduction, neuroscience, and cardiovascular biology research.
Structural Genomics Consortium (SGC) chemical probes for target validation and numerous additional research applications and workflow needs.

